Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
Margaret Meagher(University of California San Diego), Ithaar Derweesh(Rush University Medical Center), Aaron Bradshaw(University of California San Diego), Enrico Checcucci(University of Turin), Alberto Antonelli, Estefanía Linares(Hospital Universitario La Paz), N. Pavan(University of Trieste), Devang M. Patel, Michele Marchioni(University of Chieti-Pescara), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Campi(University of Florence), Riccardo Autorino(Rush University Medical Center), M. Kriegmair(Urologische Klinik München), Thomas Amiel(Technical University of Munich), Renée M. McKay(The University of Texas Southwestern Medical Center), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Fady Ghali(University of California San Diego), Mujahid Ahmad Mir, E. Rousel(University of California San Diego), F. Porpiglia(Ospedale San Luigi Gonzaga), J. Rubió, Andrea Mari(Azienda Ospedaliero-Universitaria Careggi), M. Heck(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Vital Hevia(Hospital Universitario Ramón y Cajal)
Cited by 0
Related Papers
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Supine Valdivia and modified lithotomy position for simultaneous anterograde and retrograde endourological access
|British Journal of Urology|2007|288
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
NIFEDIPINE VERSUS TAMSULOSIN FOR THE MANAGEMENT OF LOWER URETERAL STONES
|The Journal of Urology|2004|242